New on YCharts: We've added nearly 10,000 securities to our database with coverage of OTCMARKETS HIDE

Seattle Genetics (SGEN)

Create an Alert
31.98 -0.75  -2.29%   NASDAQ Jun 17, 8:00PM BATS Real time Currency in USD

Seattle Genetics R&D Expense Quarterly:

47.74M for March 31, 2013
View Full Chart

Seattle Genetics R&D Expense Quarterly Chart

    Seattle Genetics Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 47.74M
    Dec. 31, 2012 47.66M
    Sept. 30, 2012 41.39M
    June 30, 2012 42.76M
    March 31, 2012 38.49M
    Dec. 31, 2011 40.24M
    Sept. 30, 2011 41.08M
    June 30, 2011 49.64M
    March 31, 2011 32.43M
    Dec. 31, 2010 32.52M
    Sept. 30, 2010 44.29M
    June 30, 2010 39.29M
    March 31, 2010 30.32M
    Dec. 31, 2009 28.92M
    Sept. 30, 2009 28.26M
    June 30, 2009 28.71M
    March 31, 2009 33.25M
    Dec. 31, 2008 37.58M
    Sept. 30, 2008 27.71M
    June 30, 2008 23.50M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    SGEN R&D Expense Quarterly Benchmarks

    Companies
    Anika Therapeutics 1.583M
    ACADIA Pharmaceuticals 4.43M
    Onyx Pharmaceuticals 91.30M

    SGEN R&D Expense Quarterly Rankings

    Overall 98th percentile
    328 of 16773
    Sector 94th percentile
    81 of 1408 in Healthcare
    Industry 95th percentile
    20 of 453 in Biotechnology

    SGEN R&D Expense Quarterly Range, Past 5 Years

    Minimum 23.50M Jun 2008
    Maximum 49.64M Jun 2011
    Average 36.79M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');